Idenix Pharmaceuticals Articles

New briefs on Pfizer interest in Protalix; Novo Nordisk warning letter; Hemispherx' Ampligen; and Idenix' hep C program

6 February 2013

Idenix plunges as FDA puts clinical hold on hepatitis C drug candidate

17 August 2012

Novartis restructures deal with Idenix Pharmaceuticals

1 August 2012

News of clinical hold on AIDS drug sees Idenix Pharma shares plunge 25%

10 February 2011

Idenix Pharma slumps as US FDA puts “clinical hold” on two of the firm’s hepatitis C programs

8 September 2010

Showing 1-5 of 5 articles

Go to beginningPrevious
  • 1
NextGo to end